Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Cautela

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
La Revue Du Praticien|March 15, 2019
[How to organise cardiovascular management of cancer patients?]Franck Thuny, Jennifer Cautela
La Revue Du Praticien|April 3, 2020
[Valvular heart disease]Jennifer Cautela, Franck Thuny
European Journal of Preventive Cardiology|March 18, 2025
SGLT2 Inhibitors in Cancer Patients: A Paradigm Shift in Cardio-Oncology?Jennifer Cautela, Joachim Alexandre
Circulation|December 9, 2015
Letter by Thuny and Cautela Regarding Article, "Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry"Franck Thuny, Jennifer Cautela
JAMA Cardiology|March 9, 2017
Potential of OncocardiologyJennifer Cautela, Nathalie Lalevee, Franck Thuny
Archives of Cardiovascular Diseases|August 18, 2023
Overcoming challenges of immune checkpoint inhibitor-induced myocarditis diagnosisJennifer Cautela, Francois Deharo, Franck Thuny
Archives of Cardiovascular Diseases|January 9, 2018
Response to the letter: The high burden of coronary artery disease in heart failure with preserved ejection fractionFranck Thuny, Lory Trevisan, Jennifer Cautela
Current Treatment Options in Oncology|March 4, 2022
Cancer Therapies and Vascular ToxicitiesAlexandra Meilhac, Jennifer Cautela, Franck Thuny
JACC. Cardiooncology|January 13, 2023
What Is the Evidence of the Diagnostic Criteria and Screening of Immune Checkpoint Inhibitor-Induced Myocarditis?Franck Thuny, Marc P Bonaca, Jennifer Cautela
JACC. Clinical Electrophysiology|May 16, 2018
For Whom the Bell TollsMichaël Peyrol, Jennifer Cautela, Franck Thuny, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
La Revue Du Praticien|March 15, 2019
[How to organise cardiovascular management of cancer patients?]Franck Thuny, Jennifer Cautela
La Revue Du Praticien|April 3, 2020
[Valvular heart disease]Jennifer Cautela, Franck Thuny
European Journal of Preventive Cardiology|March 18, 2025
SGLT2 Inhibitors in Cancer Patients: A Paradigm Shift in Cardio-Oncology?Jennifer Cautela, Joachim Alexandre
Circulation|December 9, 2015
Letter by Thuny and Cautela Regarding Article, "Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry"Franck Thuny, Jennifer Cautela
JAMA Cardiology|March 9, 2017
Potential of OncocardiologyJennifer Cautela, Nathalie Lalevee, Franck Thuny
Archives of Cardiovascular Diseases|August 18, 2023
Overcoming challenges of immune checkpoint inhibitor-induced myocarditis diagnosisJennifer Cautela, Francois Deharo, Franck Thuny
Archives of Cardiovascular Diseases|January 9, 2018
Response to the letter: The high burden of coronary artery disease in heart failure with preserved ejection fractionFranck Thuny, Lory Trevisan, Jennifer Cautela
Current Treatment Options in Oncology|March 4, 2022
Cancer Therapies and Vascular ToxicitiesAlexandra Meilhac, Jennifer Cautela, Franck Thuny
JACC. Cardiooncology|January 13, 2023
What Is the Evidence of the Diagnostic Criteria and Screening of Immune Checkpoint Inhibitor-Induced Myocarditis?Franck Thuny, Marc P Bonaca, Jennifer Cautela
JACC. Clinical Electrophysiology|May 16, 2018
For Whom the Bell TollsMichaël Peyrol, Jennifer Cautela, Franck Thuny, et al.
Pageof 7